| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 23 |
| 1 | ACETAMINOPHEN | 13 |
| 2 | CYCLOPHOSPHAMIDE | 12 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 12 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 12 |
| 5 | ACETAMINOPHEN 500MG | 11 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 11 |
| 7 | ASPIRIN | 11 |
| 8 | ASPIRIN 325 MG | 11 |
| 9 | ASPIRIN 81 MG | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLORAZEPATE DIPOTASSIUM | 7 | 0.0036 |
| 1 | DIMETICONE | 1 | 0.0035 |
| 2 | MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | 1 | 0.0016 |
| 3 | IMIPENEM AND CILASTATIN SODIUM | 2 | 0.0009 |
| 4 | STREPTOMYCIN | 1 | 0.0009 |
| 5 | ANAGRELIDE HYDROCHLORIDE | 1 | 0.0009 |
| 6 | SARGRAMOSTIM | 1 | 0.0006 |
| 7 | CALCIUM ACETATE | 3 | 0.0006 |
| 8 | PEGFILGRASTIM | 6 | 0.0005 |
| 9 | PROPYLTHIOURACIL | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 29 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 2 | Corticosteroid [EPC] | 18 |
| 3 | Alkylating Drug [EPC] | 14 |
| 4 | Benzodiazepine [EPC] | 13 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 12 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 7 | Platinum-based Drug [EPC] | 11 |
| 8 | Leukocyte Growth Factor [EPC] | 10 |
| 9 | Microtubule Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leukotriene Receptor Antagonist [EPC] | 7 | 0.0002 |
| 1 | Barbiturate [EPC] | 2 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 4 | Alkaloid [EPC] | 4 | 0.0002 |
| 5 | Estrogen Receptor Antagonist [EPC] | 6 | 0.0001 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 12 | 0.0001 |
| 7 | Vitamin K [EPC] | 1 | 0.0001 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Antimalarial [EPC] | 1 | 0.0001 |